Galmed Pharmaceuticals (GLMD) EBT (2013 - 2020)

Galmed Pharmaceuticals' EBT history runs 8 years deep, the most recent figure standing at $6.9 million for Q1 2020.

• In Q1 2020, EBT rose 49.54% year-over-year to $6.9 million; the TTM figure through Mar 2020 stood at $24.2 million (up 104.41% YoY), while the FY2024 annual figure was $1.7 million, up 8.74% from the prior year.
• EBT was $6.9 million for Q1 2020 at Galmed Pharmaceuticals, down from $8.3 million in the prior quarter.
• In the past five years, EBT ranged from a high of $8.3 million in Q4 2019 to a low of $884000.0 in Q3 2018.
• Historically, EBT has averaged $4.0 million across 5 years, with a median of $3.7 million in 2016.
• The sharpest annual moves came in 2018 and 2019: EBT tumbled 68.44% in 2018, then soared 410.63% in 2019.
• A 5-year view of EBT shows it stood at $4.8 million in 2016, then dropped by 24.49% to $3.6 million in 2017, then grew by 1.7% to $3.7 million in 2018, then surged by 123.58% to $8.3 million in 2019, then retreated by 17.2% to $6.9 million in 2020.
• The last three EBT figures came in at $6.9 million (Q1 2020), $8.3 million (Q4 2019), and $4.5 million (Q3 2019), per Business Quant data.